Cargando…

Conversion to Sirolimus Ameliorates Cyclosporine-Induced Nephropathy in the Rat: Focus on Serum, Urine, Gene, and Protein Renal Expression Biomarkers

Protocols of conversion from cyclosporin A (CsA) to sirolimus (SRL) have been widely used in immunotherapy after transplantation to prevent CsA-induced nephropathy, but the molecular mechanisms underlying these protocols remain nuclear. This study aimed to identify the molecular pathways and putativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sereno, José, Nunes, Sara, Rodrigues-Santos, Paulo, Vala, Helena, Rocha-Pereira, Petronila, Fernandes, João, Santos-Silva, Alice, Teixeira, Frederico, Reis, Flávio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055143/ https://www.ncbi.nlm.nih.gov/pubmed/24971338 http://dx.doi.org/10.1155/2014/576929

Ejemplares similares

Transition from Cyclosporine-Induced Renal Dysfunction to Nephrotoxicity in an in Vivo Rat Model
por: Sereno, José, et al.
Publicado: (2014)

Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model
por: Sereno, José, et al.
Publicado: (2012)

Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy
por: Kim, Jin Young, et al.
Publicado: (2012)

The combined use of sirolimus and cyclosporin in the management of refractory minimal change nephropathy: ‘a novel use of sirolimus’
por: Davison, Rachel, et al.
Publicado: (2009)

Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties
por: Mega, Cristina, et al.
Publicado: (2014)

Markers of Increased Cardiovascular Risk in Postmenopausal Women: Focus on Oxidized-LDL and HDL Subpopulations
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
por: Mega, Cristina, et al.
Publicado: (2011)

Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013)

Preventive but Not Curative Efficacy of Celecoxib on Bladder Carcinogenesis in a Rat Model
por: Sereno, José, et al.
Publicado: (2010)

Chemopreventive Efficacy of Atorvastatin against Nitrosamine-Induced Rat Bladder Cancer: Antioxidant, Anti-Proliferative and Anti-Inflammatory Properties
por: Parada, Belmiro, et al.
Publicado: (2012)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)
por: Ferreira, Liliana, et al.
Publicado: (2010)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Iron-Hepcidin Dysmetabolism, Anemia and Renal Hypoxia, Inflammation and Fibrosis in the Remnant Kidney Rat Model
por: Garrido, Patrícia, et al.
Publicado: (2015)

Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia
por: Garrido, Patrícia, et al.
Publicado: (2015)

Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

The role of sirolimus in proteinuria in diabetic nephropathy rats
por: Wang, JinJun, et al.
Publicado: (2017)

Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells
por: O'Connell, Séin, et al.
Publicado: (2012)

In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus against Aspergillus Species
por: Schwarz, Patrick, et al.
Publicado: (2020)

Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties
por: Teixeira-Lemos, Edite, et al.
Publicado: (2011)

Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results
por: Thervet, Eric
Publicado: (2006)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Simultaneous Determination of Cyclosporine A, Tacrolimus, Sirolimus, and Everolimus in Whole-Blood Samples by LC-MS/MS
por: Karapirli, Mustafa, et al.
Publicado: (2012)

Application of Allogeneic Bone Marrow Cells in View of Residual Alloreactivity: Sirolimus but Not Cyclosporine Evolves Tolerogenic Properties
por: Timrott, Kai, et al.
Publicado: (2015)

Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats
por: Rubert, Mercedes, et al.
Publicado: (2015)

Established and Newly Proposed Mechanisms of Chronic Cyclosporine Nephropathy
por: Yoon, Hye Eun, et al.
Publicado: (2009)

The SMART trial; does it make us wiser in choosing between sirolimus in preference to cyclosporine – A postrenal transplant?
por: Mishra, Ankit
Publicado: (2021)

New Markers of Early Cardiovascular Risk in Multiple Sclerosis Patients: Oxidized-LDL Correlates with Clinical Staging
por: Palavra, Filipe, et al.
Publicado: (2013)

Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus
por: Alkhunaizi, Ahmed M., et al.
Publicado: (2020)

Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults
por: Groll, Andreas H., et al.
Publicado: (2016)

Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study
por: Yang, Yuan, et al.
Publicado: (2023)

Successful Amelioration of Inflammatory Linear Verrucous Epidermal Nevus with Topical Sirolimus
por: Patel, Nayankumar, et al.
Publicado: (2020)

Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
por: Marques, Catarina, et al.
Publicado: (2014)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse
por: Nguyen, Long T., et al.
Publicado: (2021)

Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)

Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy
por: Preguiça, Inês, et al.
Publicado: (2020)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype
por: Carroll, Robert P., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nvusf9fu6noqkfss2meojjvkev